{"The": [0], "receptor": [1, 15], "binding": [2], "domain": [3], "(RBD)": [4], "of": [5, 21, 28, 45, 86, 135, 144], "the": [6, 41, 69], "SARS-CoV-2": [7, 120], "spike": [8], "glycoprotein": [9], "mediates": [10], "viral": [11, 148], "attachment": [12], "to": [13, 40, 132], "ACE2": [14, 61, 94, 98], "and": [16, 24, 48, 60, 63, 79, 128, 141], "is": [17], "a": [18, 25, 83], "major": [19], "determinant": [20], "host": [22], "range": [23], "dominant": [26], "target": [27], "neutralizing": [29], "antibodies.": [30], "Here,": [31], "we": [32, 64, 107], "experimentally": [33], "measure": [34], "how": [35], "all": [36], "amino": [37], "acid": [38], "mutations": [39, 54, 87, 114, 145], "RBD": [42, 58], "affect": [43], "expression": [44, 59], "folded": [46], "protein": [47], "its": [49], "affinity": [50], "for": [51, 57, 77, 138], "ACE2.": [52], "Most": [53], "are": [55, 88], "deleterious": [56], "binding,": [62, 95], "identify": [65], "constrained": [66], "regions": [67], "on": [68], "RBD's": [70], "surface": [71], "that": [72, 101, 111], "may": [73], "be": [74], "desirable": [75], "targets": [76], "vaccines": [78], "antibody-based": [80], "therapeutics.": [81], "But": [82], "substantial": [84], "number": [85], "well": [89], "tolerated": [90], "or": [91], "even": [92], "enhance": [93], "including": [96], "at": [97], "interface": [99], "residues": [100], "vary": [102], "across": [103], "SARS-related": [104], "coronaviruses.": [105], "However,": [106], "find": [108], "no": [109], "evidence": [110], "these": [112], "ACE2-affinity-enhancing": [113], "have": [115], "been": [116], "selected": [117], "in": [118], "current": [119], "pandemic": [121], "isolates.": [122], "We": [123], "present": [124], "an": [125], "interactive": [126], "visualization": [127], "open": [129], "analysis": [130], "pipeline": [131], "facilitate": [133], "use": [134], "our": [136], "dataset": [137], "vaccine": [139], "design": [140], "functional": [142], "annotation": [143], "observed": [146], "during": [147], "surveillance.": [149]}